Methods of Administering an AMPA Receptor Antagonist to Treat Dyskinesias Associated with Dopamine Agonist Therapy

Details for Australian Patent Application No. 2002300534 (hide)

Owner Pfizer Products Inc. Greenamyre, J.

Inventors Chenard, Bertrand Leo; Welch Jr, Willard McKowan; Greenamyre, John Timothy; Menniti, Frank Samuel

Agent Spruson & Ferguson

Pub. Number AU-A-2002300534

Parent 83193

Filing date 14 August 2002

Wipo publication date 13 February 2003

International Classifications

A61K 031/19

A61K 031/16 - Amides, e.g. hydroxamic acids

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002300534

3 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300535-Plank Support Stand

2002300533-Containers with variable volume